Technical Analysis for MRNA - Moderna, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical MRNA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Doji - Bullish? | Reversal | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -2.59% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -8.15% | |
| Narrow Range Bar | Range Contraction | -8.15% | |
| Outside Day | Range Expansion | -8.15% | |
| Wide Bands | Range Expansion | -8.15% | |
| 180 Bearish Setup | Bearish Swing Setup | -7.53% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 2 days ago |
| Up 1% | 2 days ago |
| 1.5x Volume Pace | 2 days ago |
| Down 3% | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/23/2022
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: S&P 500 Cancer Life Sciences Biology Nasdaq 100 Vaccines Coronavirus Cancer Vaccine RNA Messenger RNA
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: S&P 500 Cancer Life Sciences Biology Nasdaq 100 Vaccines Coronavirus Cancer Vaccine RNA Messenger RNA
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 497.17 |
| 52 Week Low | 117.3411 |
| Average Volume | 12,735,817 |
| 200-Day Moving Average | 278.24 |
| 50-Day Moving Average | 259.61 |
| 20-Day Moving Average | 239.43 |
| 10-Day Moving Average | 220.61 |
| Average True Range | 18.88 |
| ADX | 17.7 |
| +DI | 17.76 |
| -DI | 30.14 |
| Chandelier Exit (Long, 3 ATRs) | 264.67 |
| Chandelier Exit (Short, 3 ATRs) | 256.71 |
| Upper Bollinger Bands | 285.34 |
| Lower Bollinger Band | 193.52 |
| Percent B (%b) | 0.12 |
| BandWidth | 38.35 |
| MACD Line | -17.49 |
| MACD Signal Line | -15.74 |
| MACD Histogram | -1.749 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 223.73 | ||||
| Resistance 3 (R3) | 224.29 | 218.52 | 220.56 | ||
| Resistance 2 (R2) | 218.52 | 213.68 | 218.24 | 219.50 | |
| Resistance 1 (R1) | 211.62 | 210.69 | 215.07 | 211.06 | 218.45 |
| Pivot Point | 205.85 | 205.85 | 207.58 | 205.57 | 205.85 |
| Support 1 (S1) | 198.96 | 201.01 | 202.41 | 198.40 | 191.01 |
| Support 2 (S2) | 193.19 | 198.02 | 192.91 | 189.96 | |
| Support 3 (S3) | 186.29 | 193.19 | 188.90 | ||
| Support 4 (S4) | 185.73 |
